Home
About Us
About Boan
Culture
Our History
Our Team
Responsibility
R&D
Technology platform
Boan Product Pipeline
Intellectual Property
Production capacity
Products
News
Careers
People Strategy
Employee Stories
Development
Job Opportunities
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Contact us
简
/
繁
/
EN
News
Year
2021
2022
2023
Month
1
2
3
4
5
6
7
8
9
10
11
12
11
2023-04
BLA for Boan's Boyounuo® (Bevacizumab) Accepted in Brazil
28
2023-03
Boan Biotech Announces 2022 Financial Results
21
2023-03
BLA Accepted in China for Boan Biotech’s Denosumab Injection (BA1102) for the Oncology Indications
15
2023-03
Boan Biotech Announces Publication of Phase 1 Clinical Study Results of BA5101 in the Journal of Expert Opinion on Biological Therapy
14
2023-03
Patient Enrollment Completed for BA9101 Phase 3 Clinical Study
16
2023-02
Boan’s BA2101 Administered for First Patient in Clinical Trial
13
2023-02
Boan’s BA1106 Administered for First Patient in Clinical Trial
13
2023-01
Boan Biotech Publishes Research Results of Self-Developed Neutralizing Antibody Against SARS-CoV-2 Variants in Nature Sub-Journal
03
2023-02
Boan Biotech Partners with CP Qingdao to Accelerate the Commercialization of Boyoubei® in China
09
2023-01
Boan Biotech’s First Investigational ADC, BA1301 for Injection, Approved for Clinical Trials in China
1
2
3
4
5
Follow me
